Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Research Deep Sleep Considerations: Comparison

Primary Mechanism Actin-binding, cytoskeletal remodelling, angiogenesis GI-tract signalling, nitric oxide modulation GABA-A receptor agonism (sedation), melatonin receptor activation TB-500 modulates repair signalling during existing sleep; others address slee

This comparison does not assign a generated winner or score.

  • Primary Mechanism
  • Actin-binding, cytoskeletal remodelling, angiogenesis
  • GI-tract signalling, nitric oxide modulation
  • GABA-A receptor agonism (sedation), melatonin receptor activation
  • TB-500 modulates repair signalling during existing sleep; others address sleep initiation or maintenance
  • Effect on Sleep Architecture
  • Extends delta-wave epoch duration, delays REM onset by ~20 min
  • Minimal direct sleep impact; indirect via pain reduction
  • Reduces sleep latency, increases total sleep time, no structural change
  • TB-500 alters deep-sleep quality; supplements increase quantity
  • Half-Life
  • 14–21 days (human extrapolation)
  • 4–6 hours (estimated)
  • 20–50 minutes (GABA), 40–60 minutes (melatonin)
  • TB-500's extended half-life supports sustained effects across multiple cycles
  • Dosing Timing Sensitivity
  • High. Evening dosing 60–120 min before sleep onset optimal
  • Moderate. Typically dosed twice daily
  • High. Melatonin must align with circadian nadir
  • TB-500 requires circadian alignment for maximal repair-phase overlap
  • Research Evidence for Sleep
  • Preclinical models show 34% increase in delta activity; human case series limited
  • No direct sleep studies; anecdotal reports of improved rest via pain relief
  • Extensive clinical data for sleep latency; minimal for architecture
  • TB-500 has the strongest mechanistic rationale for deep-sleep enhancement
  • Bottom Line
  • Best for optimising recovery-phase sleep architecture in physically stressed populations
  • Secondary sleep benefit via tissue repair and pain modulation
  • First-line for sleep onset issues; does not address repair signalling
  • TB-500 is the only option that directly modulates the anabolic signalling environment during slow-wave sleep
More references

Related material